The parenteral nutrition market is likely to witness exponential growth in the coming years owing to the increasing prevalence of malnutrition across the globe. In fact, according to WHO, nearly 45% of deaths among children under the age of 5 years occur because of undernutrition. Meanwhile, growing geriatric population is also leading to higher demand for parenteral nutrition, further supporting industry growth. This is mainly because individuals aged 65 and above are more prone to chronic diseases. Combined, the above-mentioned factors are expected to generate a significant growth impetus for the market in coming years. 

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3216

With respect to composition, the amino acids segment is expected to grow at a CAGR of more than 3.8% over the forecast time period. Rising prevalence of hepatic insufficiency, protein-energy malnutrition, and renal insufficiency will impel the demand of amino acid-rich parenteral products. Subsequently, rising case of such diseases will augment the parenteral nutrition market growth.

In terms of consumer, child parenteral nutrition segment held a valuation of over $1,820.8 million in 2018 and is projected to witness substantial growth through the forecast timeframe. The anticipated growth is ascribed to the rising occurrence of several chronic disorders in newborns. Furthermore, various pediatric disorders like bronchitis, anemia, tuberculosis, leukemia, chicken pox, and asthma are expected to create a higher demand for parenteral nutrition products, further supporting market growth.

U.S. parenteral nutrition market growth shall be augmented by the increase in awareness about the importance of various healthcare solutions, along with surging chronic conditions and healthcare expenses. With the presence of leading industry firms such as ICU Medical, being led by international pediatric nutrition, the U.S. parenteral nutrition regional market share is projected to grow considerably at 3.3% CAGR up to 2025.

Contrastingly, the growing trend of consuming nutrients deficient junk food has resulted in rising instances of non-communicable diseases such as hypertension, obesity, diabetes, and other metabolic disorders which will trigger substantial demand for parenteral nutrition for adults. Prominent firms that have a strong presence in the industry are Baxter International, Inc, Aculife Healthcare, Fresenius Kabi, Guangzhou Baiyunshan Mingxing Pharmaceutical Co. Ltd., Grifols International S.A, Guangzhou Green Cross Pharmaceuticals, ICU Medical, and B. Braun Melsungen AG.

Request for customization @ https://www.decresearch.com/roc/3216

Partial Chapter of the Table of Content

Chapter 5. Parenteral Nutrition Market, By Consumer

5.1. Global market share by consumer, 2018 & 2025

5.2. Children and newborns

5.2.1. Market size, by region, 2014 – 2025 (USD Million)

5.3. Adults

5.3.1. Market size, by region, 2014 – 2025 (USD Million)

Chapter 6. Parenteral Nutrition Market, By End-use

6.1. Global parenteral nutrition market share by end-use, 2018 & 2025

6.2. Hospitals

6.2.1. Market size, by region, 2014 – 2025 (USD Million)

6.3. Clinics

6.3.1. Market size, by region, 2014 – 2025 (USD Million)

6.4. Homecare

6.4.1. Market size, by region, 2014 – 2025 (USD Million)

6.5. Others

6.5.1. Market size, by region, 2014 – 2025 (USD Million)

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/parenteral-nutrition-market